Melbourne biotech PolyActiva says it hopes to be the next Cochlear by selling its eye drug dispensing system to millions ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

Melbourne-based biotech firm PolyActiva, which has spent 15 years developing an eye-implant technology to treat glaucoma, has ...

TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

Since launching in late 2023, the NRF has backed companies, including $32 million for Harrison.ai, $ 13 million for Quantum Brilliance, and $25 million for Myriota. Despite that, the PolyActiva deal ...

The international biotechnology company BeiGene is moving its legal headquarters from the Cayman Islands to Basel. In ...

AI is reshaping labs and Clever Culture’s tech is gaining Big Pharma attention as diagnostics and cleanrooms go digital.

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...

Channel Therapeutics reports CT2000 reduced eye pain in preclinical trials, with plans to enter human testing for acute and ...

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

Looking to reduce dark circles or fine lines? There’s an eye treatment to suit. Plus, experts tell us what an eye cream for ...